A question mark used to intrigue potential investors or traders.

COVID-19 Testing Kit $MIR: Canadian/Swiss/American Collab

Testing Kit Technically Speaking

COVID-19 testing kit companies continue to move in the markets. We mentioned $SONA last week and now turn our attention towards MedMira (MIR). MIR is a medical devices company who have access to the US market through Webb Diagnostics. A series of news articles found here on the Webb website show the recent progression and that the two companies are awaiting FDA approval. As a result $MIR has direct exposure to US as well as Canadian investors which may make it an attractive choice. Technically this hourly chart looks to have potential:

COVID-19 Testing Kit
Figure 1: $MIR hourly chart with candles, volume, and RSI.

This hourly chart makes MIR look like a solid swing play. Indeed, we have been swinging MIR multiple times with entries in the .20s and exits in the mid .30s. However, the next chart shows that this one may explode once again:

COVID-19 Testing Kit
Figure 2: Daily chart of MIR with RSI about to enter undersold territory.

Grizzly Financials

Given that MIR and Webb are currently awaiting FDA news it is not surprising to see this period of consolidation with high chance to move. As a result of seeing these technicals we looked further into the fundamental structure of MIR which did not yield great results. As of FY2020 ended January 31st the company does not look to be in good condition financially:

  • 658,364,320 outstanding common shares and 5,000,000 Series A shares at 0.33 a piece gives a market cap of ~218M. However, company has the option to issue unlimited common shares at anytime which is dilution potential.
  • FY2020 operating loss of 1M with only $155K cash on hand
  • Negative cash flow of 0.6M
  • 6 short term loans in default totalling 9.3M with total commitments of 17M. Debt is currently in negotiations for restructuring.

It was also found that a walloping 70% of the shares are owned by On Site Lab Holding AG which is a Swiss investment holding company. As a result this company is the controlling shareholder and also has a doctor on the board of directors.

COVID-19 Testing Kit Comparison

Unlike SONA neither MIR nor Webb have disclosed the price of their kits. They have also not mentioned their production capacity or ability for expansion. What we do know is that they are working on a rapid vertical flow kit (RVF) whereas SONA is optimizing their lateral flow kit (LF). MIR has mentioned the benefits that RVF have over LF in a chart listed on their website but we suspect this is simply to give them the competitive edge. Furthermore the differences in speed and readability do not seem to be massive in comparison to other tests currently being used on the market; we have all seen the inaccuracies as well as the lengthy test times from multiple news outlets.

The Bottom Line

The bottom line in all of this is that as a long term investment MIR would absolutely need to capitalize on their kit during this pandemic to even stay afloat. As previously mentioned it has been excellent for swing trades but the lack of transparency with respect to distribution and the financials take away from this stock’s merit. Thus some of us have reduced our core positions but we still believe

One thought on “COVID-19 Testing Kit $MIR: Canadian/Swiss/American Collab

  1. Medmira has a history of being a drama queen — they say they have the greatest and then NOTHING HAPPENS —
    very leary about this company

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s